Try our beta test site
13 studies found for:    (lymphoma [CONDITION] OR CLL [CONDITION]) AND Azacytidine [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
1 Recruiting A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma
Interventions: Drug: Oral Azacitidine;   Drug: Rituximab;   Drug: cyclophosphamide;   Drug: Vincristine;   Drug: Prednisone
2 Recruiting Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies
Interventions: Drug: Romidepsin;   Drug: Oral 5-Azacitidine
3 Recruiting Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL
Interventions: Biological: Antigen-Escalation Stage;   Biological: Dose-Escalation Stage;   Biological: 5-azacytidine and multiTAA T cells Stage;   Biological: Pediatric multiTAA T cells Stage
4 Recruiting Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation
Intervention: Drug: Azacitidine
5 Recruiting Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Interventions: Drug: CC-486;   Drug: Vidaza
6 Recruiting Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
Interventions: Biological: Avelumab;   Biological: Utomilumab;   Biological: Rituximab;   Other: Azacitidine;   Drug: Bendamustine;   Drug: Gemcitabine;   Drug: Oxaliplatin
7 Recruiting Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas
Interventions: Drug: Decitabine;   Biological: cytokine-induced killer cell
8 Not yet recruiting Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and MLL Gene Rearrangement
Interventions: Drug: Azacitidine;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Hydrocortisone Sodium Succinate;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Pegaspargase;   Other: Pharmacological Study;   Drug: Prednisolone;   Drug: Thioguanine;   Drug: Vincristine Sulfate
9 Not yet recruiting p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid Malignancies
Interventions: Drug: Decitabine;   Drug: Tetrahydrouridine
10 Recruiting Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation
Interventions: Drug: azacitidine;   Biological: donor lymphocyte infusion
11 Recruiting Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation
Interventions: Drug: Fludarabine;   Radiation: Fractionated total body irradiation;   Drug: Busulfan;   Drug: Cyclophosphamide;   Radiation: Single dose total body irradiation;   Drug: Melphalan;   Drug: Granulocyte-colony stimulating factor;   Procedure: Stem cell transplant;   Drug: Azacitidine
12 Recruiting Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: Decitabine
13 Recruiting High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
Interventions: Other: Chemosensitivity Assay;   Other: Cytology Specimen Collection Procedure;   Genetic: Gene Expression Analysis;   Drug: In Vitro Sensitivity-Directed Chemotherapy;   Genetic: Mutation Analysis

Study has passed its completion date and status has not been verified in more than two years.